These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 18448618)

  • 1. Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.
    Forrest BD; Pride MW; Dunning AJ; Capeding MR; Chotpitayasunondh T; Tam JS; Rappaport R; Eldridge JH; Gruber WC
    Clin Vaccine Immunol; 2008 Jul; 15(7):1042-53. PubMed ID: 18448618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings.
    Madan RP; Tan M; Fernandez-Sesma A; Moran TM; Emre S; Campbell A; Herold BC
    Clin Infect Dis; 2008 Mar; 46(5):712-8. PubMed ID: 18230041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children.
    Bernstein DI; Yan L; Treanor J; Mendelman PM; Belshe R;
    Pediatr Infect Dis J; 2003 Jan; 22(1):28-34. PubMed ID: 12544405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults.
    Block SL; Yi T; Sheldon E; Dubovsky F; Falloon J
    Vaccine; 2011 Nov; 29(50):9391-7. PubMed ID: 21983154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and immunogenicity of influenza vaccine in HIV-infected children: a randomized, double-blind, placebo controlled trial.
    Madhi SA; Dittmer S; Kuwanda L; Venter M; Cassim H; Lazarus E; Thomas T; Liberty A; Treurnich F; Cutland CL; Weinberg A; Violari A
    AIDS; 2013 Jan; 27(3):369-79. PubMed ID: 23032417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of influenza vaccine-induced cell-mediated immunity: Comparison between methods using peripheral blood mononuclear cells and whole blood.
    Otani N; Shima M; Ueda T; Ichiki K; Nakajima K; Takesue Y; Okuno T
    Microbiol Immunol; 2019 Jun; 63(6):223-228. PubMed ID: 31070266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
    Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
    Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.
    Belshe RB; Swierkosz EM; Anderson EL; Newman FK; Nugent SL; Maassab HF
    J Infect Dis; 1992 Apr; 165(4):727-32. PubMed ID: 1552202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Preexisting Immunity on Virus Detection and Immune Responses in a Phase II, Randomized Trial of a Russian-Backbone, Live, Attenuated Influenza Vaccine in Bangladeshi Children.
    Brickley EB; Wright PF; Khalenkov A; Neuzil KM; Ortiz JR; Rudenko L; Levine MZ; Katz JM; Brooks WA
    Clin Infect Dis; 2019 Aug; 69(5):786-794. PubMed ID: 30481269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
    Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
    Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
    Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
    Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boosting of Cross-Reactive and Protection-Associated T Cells in Children After Live Attenuated Influenza Vaccination.
    Mohn KGI; Zhou F; Brokstad KA; Sridhar S; Cox RJ
    J Infect Dis; 2017 May; 215(10):1527-1535. PubMed ID: 28368530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of neutralizing antibody and cell-mediated immune responses to pandemic H1N1 2009 influenza virus before and after H1N1 2009 influenza vaccination of elderly subjects and healthcare workers.
    Hsu JP; Phoon MC; Koh GC; Chen MI; Lee VJ; Wu Y; Xie ML; Cheong A; Leo YS; Chow VT
    Int J Infect Dis; 2012 Aug; 16(8):e621-7. PubMed ID: 22704721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity and Viral Shedding of Russian-Backbone, Seasonal, Trivalent, Live, Attenuated Influenza Vaccine in a Phase II, Randomized, Placebo-Controlled Trial Among Preschool-Aged Children in Urban Bangladesh.
    Lewis KDC; Ortiz JR; Rahman MZ; Levine MZ; Rudenko L; Wright PF; Katz JM; Dally L; Rahman M; Isakova-Sivak I; Ilyushina NA; Matyushenko V; Fry AM; Lindstrom SE; Bresee JS; Brooks WA; Neuzil KM
    Clin Infect Dis; 2019 Aug; 69(5):777-785. PubMed ID: 30481272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children.
    Mohn KG; Brokstad KA; Islam S; Oftung F; Tøndel C; Aarstad HJ; Cox RJ
    J Infect Dis; 2020 Apr; 221(9):1528-1537. PubMed ID: 32255493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Waning Immunity at 6 Months after Both Trivalent and Quadrivalent Influenza Vaccination in Korean Children Aged 6-35 Months.
    Lee JH; Cho HK; Kim KH; Lee J; Kim YJ; Eun BW; Kim NH; Kim DH; Jo DS; Kim HM; Kim YK
    J Korean Med Sci; 2019 Dec; 34(46):e279. PubMed ID: 31779056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective, randomized, placebo-controlled evaluation of the safety and immunogenicity of three lots of intranasal trivalent influenza vaccine among young children.
    Zangwill KM; Droge J; Mendelman P; Marcy SM; Partridge S; Chiu CY; Jing J; Chang SJ; Cho I; Ward JI
    Pediatr Infect Dis J; 2001 Aug; 20(8):740-6. PubMed ID: 11734734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell mediated immune responses following revaccination with an influenza A/H5N1 vaccine.
    Mbawuike IN; Atmar RL; Patel SM; Corry DB; Winokur PL; Brady RC; Chen WH; Edwards KM; Creech CB; Walter EB; Frey SE; Belshe RB; Goll JB; Hill H; Keitel WA
    Vaccine; 2016 Jan; 34(4):547-554. PubMed ID: 26657997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison.
    Kumar A; McElhaney JE; Walrond L; Cyr TD; Merani S; Kollmann TR; Halperin SA; Scheifele DW
    Hum Vaccin Immunother; 2017 Sep; 13(9):2048-2057. PubMed ID: 28635557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.